http://rdf.ncbi.nlm.nih.gov/pubchem/patent/PE-20150192-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5a10dc651e733b8d5a1ec5684b812362
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N1-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P19-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-102
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-6037
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-715
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N1-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-102
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P19-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-102
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-20
filingDate 2013-07-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_705178163ec8a01f13e6ef55db20df52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9cf53743ef34d2cfa9e73797977f95e3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c9a54c8daa81f5dc48f0915910894cd7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c0ec7e081169ddfec72bf65a3b0f854b
publicationDate 2015-02-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber PE-20150192-A1
titleOfInvention METHOD OF PRODUCING TYPE "B" HAEMOPHILUS INFLUENZAE ANTIGENS
abstract THE INVENTION REFERS TO A METHOD FOR PRODUCING, ON AN INDUSTRIAL SCALE, A CAPSULAR POLYSACARIDE OF TYPE B HAEMOPHILUS INFLUENZAE (PRP) INTENDED FOR THE PURPOSES OF VACCINATION, ACCORDING TO WHICH A STRAIN OF HAEMOPHILIBUS INFLUENZAE IS CULTIVATED IN A MEDIUM-TYPE INFLUENZAE (HAEMOPHILUS INFLUENZAE) CROP AND THE CROP SUPERNADANT IS COLLECTED AND TREATED IN ORDER TO EXTRACT THE CAPSULAR POLYSACCHARIDE FROM IT, INCLUDING SAID CULTURE MEDIUM AT LEAST: A SOURCE OF CARBON, PROTOPORPHYRIN, SALTS, AMINO ACIDES, NADIATED, NADIATED MEANS TO REGULATE PH, CHARACTERIZED BY THAT SAID GROWING MEDIA IS CHEMICALLY DEFINED.
priorityDate 2012-07-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4971
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433298372
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID297
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559581

Total number of triples: 33.